The first oral drug therapy has been clinically used for HIV/AIDS for the past almost 20 years mainly in Africa and Asia. Speaking in Nairobi, Professor Shengxun says TIB blocks the fusion taking place between HIV and CD4 cells, stopping HIV from infecting CD4 cells. Speaking in Nairobi, Prof. Shengxun says as alternative HIV/AIDS therapy, patients using TIB can survive for more than 12 years. “HIV will rapture, or die, within 72 hours if HIV has not accessed CD4 cells. Updated Mon, August 8th 2016 at 15:10 GMT +3NAIROBI, KENYA: Nairobi based Professor Tian Shengxun has invented herbal concoction to remedy the effects of tuberculosis, HIV Aids and related complications.

Source: Standard Digital August 08, 2016 12:22 UTC